Stockreport

How Bausch + Lomb's $2.8 Billion Refi and Eye-Care Pipeline Momentum Will Impact Bausch + Lomb (BLCO) Investors [Yahoo! Finance]

Bausch + Lomb Corporation Common Shares  (BLCO) 
PDF Analyst upgrades citing a strong ophthalmology pipeline and improving efficiency have sharpened investor focus on how Bausch + Lomb is reshaping its balance sheet and g [Read more]